Description
Teclistamab also effective in patients with relapsed or refractory multiple myeloma who previously received anti-BCMA therapy
Article: Teclistamab also effective in patients with relapsed or refractory multiple myeloma who previously received anti-BCMA therapy
€3.03
Related products
-
Article: Calendar of events
€3.03 Add to cart -
Article: Highlights in respiratory oncology
€3.03 Add to cart -
Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma
€3.03 Add to cart -
Article: Highlights in urologic cancer
€3.03 Add to cart
